Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Erin Enright Insider Profile
4 Followers
Erin Enright, Director at Dynatronics, holds 1.05M shares in Dynatronics (Ticker: DYNT), holds ― shares in Eterna Therapeutics (Ticker: ERNA), holds ― shares in Amarin (Ticker: AMRN).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-4.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Erin Enright holds in companies
Most Profitable Insider Trade
The most profitable trade made by Erin Enright
Erin Enright's Trading History
Dynatronics
Apr 03, 2024
Director
Uninformative Buy
―
$488.97K
Eterna Therapeutics
―
Director
―
―
Amarin
―
Director
―
―
Biolase
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Erin Enright's performance on stock
You May Also Like
Erin Enright insider profile FAQ
What is the percentage of profitable transactions made by Erin Enright?
The percentage of profitable transactions made by Erin Enright is 50%.
What is the average return per transaction made by Erin Enright?
The average return per transaction made by Erin Enright is -4.20%.
What stocks does Erin Enright hold?
Erin Enright holds: DYNT, ERNA, AMRN, BIOL stocks.
What was Erin Enright’s latest transaction?
Erin Enright latest transaction was an Uninformative Buy of ―.
What was Erin Enright's most profitable transaction?
Erin Enright’s most profitable transaction was an Informative Buy of DYNT stock on December 1, 2017. The return on the trade was 2.90%.
What is Erin Enright's role in Dynatronics?
Erin Enright's role in Dynatronics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.